Pregnancy after breast cancer: latest evidence and practical considerations
Advancements in breast cancer care have significantly improved survival rates in women of all ages; however, young survivors face unique challenges related to fertility, pregnancy, and maternal-fetal health which may impact on their medical and psychosocial outcomes. Increasingly, young women are di...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251346648 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849688174969749504 |
|---|---|
| author | Nadia Mordenfeld Kozlovsky Ann H. Partridge Tal Sella |
| author_facet | Nadia Mordenfeld Kozlovsky Ann H. Partridge Tal Sella |
| author_sort | Nadia Mordenfeld Kozlovsky |
| collection | DOAJ |
| description | Advancements in breast cancer care have significantly improved survival rates in women of all ages; however, young survivors face unique challenges related to fertility, pregnancy, and maternal-fetal health which may impact on their medical and psychosocial outcomes. Increasingly, young women are diagnosed with breast cancer before completing their reproductive plans and goals and may undergo gonadotoxic therapies and prolonged endocrine therapy with age-related fertility decline. Pretreatment counseling is critical to manage expectations, align reproductive and treatment goals, plan future childbearing opportunities, and refer for fertility preservation interventions when needed. Evidence supports the safety of pregnancy and breastfeeding in posttreatment scenarios, with individual risks and treatment histories carefully evaluated. The growing use of novel agents like CDK4/6 inhibitors, poly-ADP-ribose polymerase inhibitors, and immune checkpoint inhibitors for which there are little to no data regarding impact on fertility highlights the urgent need for further research in this area. Patient-centered, multidisciplinary approaches applied throughout the disease trajectory remain essential to support the reproductive health and overall quality of life of young breast cancer survivors navigating the reproductive complexities of modern breast cancer treatment. |
| format | Article |
| id | doaj-art-bef2a578e3884e859c33d98276d2c8a5 |
| institution | DOAJ |
| issn | 1758-8359 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Medical Oncology |
| spelling | doaj-art-bef2a578e3884e859c33d98276d2c8a52025-08-20T03:22:04ZengSAGE PublishingTherapeutic Advances in Medical Oncology1758-83592025-06-011710.1177/17588359251346648Pregnancy after breast cancer: latest evidence and practical considerationsNadia Mordenfeld KozlovskyAnn H. PartridgeTal SellaAdvancements in breast cancer care have significantly improved survival rates in women of all ages; however, young survivors face unique challenges related to fertility, pregnancy, and maternal-fetal health which may impact on their medical and psychosocial outcomes. Increasingly, young women are diagnosed with breast cancer before completing their reproductive plans and goals and may undergo gonadotoxic therapies and prolonged endocrine therapy with age-related fertility decline. Pretreatment counseling is critical to manage expectations, align reproductive and treatment goals, plan future childbearing opportunities, and refer for fertility preservation interventions when needed. Evidence supports the safety of pregnancy and breastfeeding in posttreatment scenarios, with individual risks and treatment histories carefully evaluated. The growing use of novel agents like CDK4/6 inhibitors, poly-ADP-ribose polymerase inhibitors, and immune checkpoint inhibitors for which there are little to no data regarding impact on fertility highlights the urgent need for further research in this area. Patient-centered, multidisciplinary approaches applied throughout the disease trajectory remain essential to support the reproductive health and overall quality of life of young breast cancer survivors navigating the reproductive complexities of modern breast cancer treatment.https://doi.org/10.1177/17588359251346648 |
| spellingShingle | Nadia Mordenfeld Kozlovsky Ann H. Partridge Tal Sella Pregnancy after breast cancer: latest evidence and practical considerations Therapeutic Advances in Medical Oncology |
| title | Pregnancy after breast cancer: latest evidence and practical considerations |
| title_full | Pregnancy after breast cancer: latest evidence and practical considerations |
| title_fullStr | Pregnancy after breast cancer: latest evidence and practical considerations |
| title_full_unstemmed | Pregnancy after breast cancer: latest evidence and practical considerations |
| title_short | Pregnancy after breast cancer: latest evidence and practical considerations |
| title_sort | pregnancy after breast cancer latest evidence and practical considerations |
| url | https://doi.org/10.1177/17588359251346648 |
| work_keys_str_mv | AT nadiamordenfeldkozlovsky pregnancyafterbreastcancerlatestevidenceandpracticalconsiderations AT annhpartridge pregnancyafterbreastcancerlatestevidenceandpracticalconsiderations AT talsella pregnancyafterbreastcancerlatestevidenceandpracticalconsiderations |